Gadolinium-Enhanced MRI Can Differentiate Meniere From Vestibular Migraine

08 Aug 2023
www.drugs.com
Clinical Result
MONDAY, Aug. 7, 2023 -- Gadolinium-enhanced magnetic resonance imaging (MRI) of the inner ear can help differentiate Meniere disease (MD) from vestibular migraine (VM), according to a study published online June 26 in The Laryngoscope.
Heng Xiao, from Fujian Medical University in Fuzhou, China, and colleagues examined predictive factors for MD and VM in 87 patients (50 MD and 37 VM) who underwent intratympanic injection of gadolinium and then MRI of the inner ear 24 hours later.
The researchers found that 92 percent of the patients in the MD group developed endolymphatic hydrops, while only two patients (5.4 percent) had positive results in the VM group. The incidence of migraine was 14 and 67.7 percent in the MD and VM groups. The greater the sum of the maximum slow phase velocity of the ipsilateral (SSPVI) ear, the higher the risk for VM occurrence in multivariate regression of the two groups of patients. There was a positive correlation observed for the incidence of carsickness with incidence of VM, while a negative correlation was seen for asymmetric hearing loss (AHL) with VM diagnosis.
"Although gadolinium-enhanced MRI of the inner ear is helpful in the differential diagnosis of VM and MD, less invasive differential symptomology, including carsickness, decrease in AHL in audiology examination and increase in SSPVI of the ipsilateral ear in vestibular function examinations may also serve as diagnostic predictors of VM," the authors write.
Abstract/Full Text
Posted August 2023
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.